Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
The Journal of Biological Chemistry|May 16, 2003
Valproate induces replication-independent active DNA demethylationNancy Detich, Veronica Bovenzi, Moshe SzyfCarcinogenesis|December 23, 2003
Methylated DNA-binding protein 2 antisense inhibitors suppress tumourigenesis of human cancer cell lines in vitro and in vivoPaul M Campbell, Veronica Bovenzi, Moshe SzyfJournal of Cellular Physiology|September 26, 2009
Bradykinin protects against brain microvascular endothelial cell death induced by pathophysiological stimuliVeronica Bovenzi, Martin Savard, Josée Morin, et al.Peptides|January 20, 2009
Novel kinin B1 receptor agonists with improved pharmacological profilesJérôme Côté, Martin Savard, Veronica Bovenzi, et al.Journal of Cellular Physiology|August 23, 2018
Antitumor activity of cell-penetrant kinin B1 receptor antagonists in human triple-negative breast cancer cellsCéléna Dubuc, Martin Savard, Veronica Bovenzi, et al.Peptides|December 30, 2008
Structure-activity relationships of novel peptide agonists of the human bradykinin B2 receptorSimon Bélanger, Veronica Bovenzi, Jérome Côté, et al.Neuropeptides|January 19, 2010
Selective tumor blood-brain barrier opening with the kinin B2 receptor agonist [Phe(8)psi(CH(2)NH)Arg(9)]-BK in a F98 glioma rat model: an MRI studyJérôme Côté, Martin Savard, Veronica Bovenzi, et al.Journal of Cellular Physiology|February 12, 2008
Expression of endogenous nuclear bradykinin B2 receptors mediating signaling in immediate early gene activationMartin Savard, David Barbaz, Simon Bélanger, et al.The Journal of Gene Medicine|July 19, 2002
Antisense MBD2 gene therapy inhibits tumorigenesisAndrew Slack, Veronica Bovenzi, Pascal Bigey, et al.Oncotarget|March 9, 2018
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancerCéléna Dubuc, Martin Savard, Veronica Bovenzi, et al.Pageof 2